The kidney plays an important role in the blood pressure regulation primarily by modulating tubular sodium reabsorption. Various hormones, vasoactive peptides, autacoids and transporters or channels in renal tubules are involved in this process. Genes associated with renal tubular sodium handling are possibly related to the development of hypertension. Genes of the renin-angiotensin-aldosterone system are thought to be especially important as causal genes of hypertension. Na-K-ATPase, biochemically equal to Na pump, exists on the basolateral membrane of renal epithelial cells. It plays a central role in Na reabsorption and creates a driving force for transepithelial transport. Na-K-ATPaseactivity is regulated by adducin, a membrane-bound skeletal protein, as well as by several hormones such as dopamine, endogenous ouabain-like factor or cytochrome P450 metabolites. Genes of these factors involved in Na-K-ATPaseregulation should be related to the development of hypertension. The endothelin system, atrial natriuretic peptide and nitric oxide regulate the tonus of blood vessels as well as renal sodiumexcretion. Several reports have indicated that genes of these substances are crucial in the pathogenesis of hype rtension. (Internal Medicine 38: 919-926, 1999) 
Introduction
The physiological and biochemical processes of no single organ can account for the mechanismsof blood pressure regulation. Hencegenetic abnormalities causing the malfunction of any of the organs involved maycontribute to the development of hypertension. Amongthese organs the kidney is of central importance, as shown through physiological, biochemical, pharmacological, as well as recent genetic investigations. Since essential hypertension, which is most of humanhypertension, is primarily a polygenic disease and is subject to modification by environmental factors, the identification of a causal gene has proved difficult. In contrast, the candidate gene in experimental hypertensive rats has been elucidated by the candidate gene approach as well as by genomic screening method because the rat causal gene is homogenous. This review is an outline of the recent achievements in elucidating the genetic renal factors involved in the development of hypertension, both in experimental models and in humans.
Renin-Angiotensin-Aldosterone System
The renin-angiotensin-aldosterone system regulates the water and electrolyte balance, effective circulating blood volume and blood pressure by synthesizing angiotensin II, a potent vasoactive peptide, and aldosterone. The relationship between polymorphismof genes associated with this system and the development of hypertension has been studied extensively in recent years. Thepositive results supporting the association of this system with hypertension are summarizedin Table 1 .
Renin
The regulation of expression of the renin gene is tissue and organ specific, the major tissue involved in the production of renin being the juxtaglomerular apparatus of the kidney. A restriction fragment length polymorphism (RFLP) in the renin gene was found between Dahl salt-sensitive and Dahl salt-resistant rats (1) . In contrast, no evidence was observed in the renin genotype-dependent phenotypic difference in the reninangiotensin system that could account for the effect of the renin locus on blood pressure in Lyon rats (2) . Further investiga- tions are necessary to prove the genetic co-segregation between a polymorphism of the renin gene and hypertension. Interestingly, a recent examination using a model of spontaneously high humanrenin hypertension in the rat by producing two transgenic strains, one for humanangiotensinogen and the other for humanrenin, both with endogenous promoters, showedthat neither transgenic strain was hypertensive. These strains were crossed, however, yielding offspring with leading to death after a meanof 55 days if left untreated. These observations suggest that this double transgenic strain will facilitate the simultaneous investigation of genetic and pathophysiological aspects of renin-induced hypertension (3).
Angiotensinogen
Evidence in experimental models The genetic linkage between the angiotensinogen (AGT) gene and hypertension has also been investigated using experimental models. Kim et al (4) proved the direct association between genotypes at the AGTlocus and blood pressure using mice carrying zero, one, three or four functional copies of the murine wild-type AGTgene at its normal chromosomelocation. In the investigation using hypertensive rats, the AGTlocus in spontaneously hypertensive rat (SHR) cosegregated with a specific increase in blood pressure (5) . Furthermore, the functional significance of tissue angiotensinogen has been elucidated in SHR. The expression of tissue AGTis regulated differently in SHRand its corresponding normotensive control, the Wistar Kyoto (WKY)rat, and the development of hypertension is associated at least temporarily with increases in cardiac and adipogenic AGTmRNAin SHR (6) . The transfection of antisense oligonucleotides against rat AGTresults in a transient decrease in the high blood pressure of SHRaccompanied by a decrease both in hepatic AGTmRNAand in plasma angiotensin II levels (7).
Evidence in humanhypertension
The evidence supporting a genetic linkage between AGT and hypertension in Caucasian subjects was firstly presented by Jeunemaitre et al in 1992 who demonstrated that T174M and M235Tvariants on exon 2 of the AGTgene are associated with the development of hypertension (8) . M235T polymorphism showedan especially close correlation to the blood AGT concentration, and to the severity of hypertension. A similar linkage between M235Tvariant and human hypertension was observed in Africans (9) and in Japanese (10) subjects. However, Caulfield et al reported that there was no association between T174Mor M235Tpolymorphism and essential hypertension (ll). Therefore in conclusion it can be stated that although the AGTgene could be one of the important causal genes of essential hypertension, howmutations in this region opposed to T174Mand M235Tpolymorphisms may result in hypertension remains to be determined.
Angiotensin-Converting Enzyme
Evidence in experimental models The first evidence for the association of angiotensin-converting enzyme (ACE) locus and hypertension in experimental model rats was presented by the wide genomicscanning of the F2 generation (spontaneously hypertensive rat-stroke prone (SHRSP) XWKY)by two groups (12, 13) . Both reports indi-cate a strong association of blood pressure with the quantitative trait loci (QTL) which are close to the ACElocus on chromosome10. However, recent reports have denied the association of the ACEgene and hypertension in experimental models. Experiments in which the cDNAsfor the WKY and SHRSP were cloned and characterized indicate that an alteration of the primary structure of the rat ACEdoes not contribute to hypertension in the SHRSP (14) . The crossbreeding experiment between SHRSP and a congenic reference strain showedthat a molecular variant of the ACEgene determines plasma ACE activity but exhibits no direct effect on blood pressure (15) . Furthermore, although ACEgene polymorphismswere associated with the plasma ACEconcentration, no linkage was observed between ACEgene variant and blood pressure (16) .
Evidence in human hypertension An insertion/deletion (I/D) polymorphism of ACElocated in intron 16 has a substantial effect on plasmaACElevels (17) .
The deletion (D) allele is associated with an increased plasma ACEconcentration in normal individuals. The plasma ACE concentration is the highest in subjects with D/Dgenotype, followed by those with I/D genotype, and the lowest in those with I/I genotype. However, results concerning the association between this ACEpolymorphism with blood pressure in the human are controversial. Several studies revealed negative ( 1 8-20) , with fewer studies showing a positive correlation (21) . Though the reason of these differing results is not yet well understood, Abbud et al (22) showed that a significant association was detected between hypertension and D/D genotype of the ACEgene whenthe relation was adjusted for age, sex, and body mass index. Racial differences may also contribute to the inconsistency of these results. Interestingly, a recent report examining the interaction between I/D of ACEgene and M235T AGTgene polymorphic alleles has proved that the interaction of the I/D ACEand M235TAGTpolymorphic alleles can contribute to essential hypertension, despite the absence of single gene associations with the condition (23) . A recent report in Japanese has suggested an association with the ACEgene and the heterogeneous process of salt sensitivity in essential hypertension (24) .
Angiotensin II Receptors
Evidence in experimentai models Angiotensin II (All) is synthesized via ACEas well as kimase, one of the serin protease that generates All independent of ACE.The All receptors are classified into two subtypes, ATI and AT2. The correlation between the ATI gene and blood pressure regulation has recently been investigated. Investigations in which the mousegene encoding ATIreceptor is disrupted by gene targeting, demonstrate that ATI receptor function is required for vascular and hemodynamicresponses to All, and that altered expression of the ATI receptor gene has marked effects on blood pressure (25) . Studies using ATI receptor antisense (AT1R-AS)reveal that an injection of AT1R-AS results in a lowering of blood pressure in the spontaneously hypertensive rats. The reduction of blood pressure is associated with the expression of the AT1R-AS transcript, as well as and decreases in the ATI receptor of many peripheral All target tissues including the kidney. These observations indicate that there is a close relationship between the expression of the ATI receptor gene and blood pressure regulation in the spontaneously hypertensive rats (26) .
Evidence in human hypertension Bonnardeaux et al (27) identified the five polymorphisms ofATI receptors (T573C, A1062G, A1166C, G1517T, and A1 878G). A case-control study performed on white hypertensive and normotensive subjects using three of five polymorphisms showeda significant increase in the allele frequency of C1166 in hypertensive subjects but not in C573 or G1878. However,other recent reports failed to prove the association the Cl 166 polymorphism of the ATI receptor gene with essential hypertension (28, 29) . There was a tendency for hypertensive patients with a late age at diagnosis to have a decreased prevalence of the C1166 allele (29) . A very recent study in Japanese people suggests the gene polymorphisms of both ATI and AT2receptors are not directly involved in the increase in genetic risk of hypertension, but that the ATI receptor gene might contribute genetically to the increase of left ventricular mass (30) . Further investigation will be necessary to address the association of the polymorphismsof All receptor gene with hypertension.
SA Gene
Evidence in experimentai models The SA(subtractive clone A) gene maps onto rat chromosome 1 and encodes a protein of which the function is not understood. The expression of the SA gene in the kidney of SHR is greater than 10-fold that observed in WKYrats. The blood pressure of F2 rats inheriting two SHRalleles of the SA gene is significantly higher than that of the F2 rats inheriting two WKYalleles. These observations indicate that the SAgene, or a gene closely linked to it, has the capacity to influence the blood pressure of the F2 rat population (31) . In a study using stroke-prone SHR(SHRSP), the systolic blood pressure became elevated after sodium loading but not under basal conditions amonggroups of rats defined by zygosity at the SA locus, consistent with the hypertensive effect of the SHRSPallele. However, no effect of the SAgenotype on diastolic pressure was observed (32) . In situ hybridization of SHRand WKY rat kidney sections with a radioactive-labeled rat SAcomplementary DNAprobe showed the increased signal in the SHR to be localized at the proximal tubule (33) . Moreover, the distribution of the SA gene expression in the proximal tubule is in a strain-dependent manner; in the proximal convoluted tubule in Sprague Dawley rats; in the proximal straight tubule in the WKY;and along the entire proximal tubule in the SHR (34) . Taken together, in the SHR, the SA gene expression is augmented in the proximal tubule especially after sodium loading.
Although the physiological significance of this observation is
Internal Medicine Vol. 38, No. 12 (December 1999) not understood, it is possible that the increased SAgene expression in the proximal tubule maycontribute in part to the sodium sensitivity of SHR. Interestingly, the p-subunit of the epithelial sodium channel gene is located close to the SA gene on rat chromosome1 , involved in the inherited blood pressure control in the SHRand Dahl salt-sensitive rats (35) .
Evidence in humanhypertension
Afew studies have investigated the association of the SA gene and humanhypertension. Iwai et al (36) showed that the humanSA gene mapped onto human chromosome16 and that there were significant differences in the frequency of the A2 allele of the SA gene observed between the hypertensive and control groups in Japanese. This provides favorable evidence that the SAgene is a candidate gene for humanessential hypertension. In contrast, a cross-sectional case-control study involving white individuals did not prove the association of the SAgenotype with hypertension, but gave preliminary evidence for a possible association with variation in body mass index in a severely affected hypertensive group with a strong family history of hypertension (37) . Further studies will be necessary to identify the universal role of the SA gene in humanessential hypertension.
Adducin
Evidence in experimentai models An enhanced rate of sodium transport across the renal tubular cells contributes in part to the elevation of blood pressure in the Milan hypertensive strain (MHS), one of the genetically hypertensive model rats. This phenomenon is abolished by removing the membrane cytoskeleton. Na-K-ATPase activity in the proximal tubule in MHSis higher than that in its corresponding normotensive strain, Milan normotensive strain (MNS) (38) , and this finding is thought to be one of the mechanisms causing faster sodium transport in MHS. The adducin heterodimer with alpha and beta subunits is a membrane-bound skeletal protein affecting the assembly of the actin-based cytoskeleton. Complementary DNAsequencing of alpha-and beta-adducin subunits of MHSled to the identification of a missense mutation in each subunit. Either subunit interacts epistatically and, when both hypertensive variants are present at the homozygousstate in the same animal, they explain up to 50% of the blood pressure difference between MHSand MNS (39). Adducin is involved in the control of many cellular functions. It promotes binding between spectrin and actin in a caimodulin-dependent manner and mayplay a role in regulating the rate of ion transport across the plasma membrane. The MHSadducin variants affect actin assembly differently from MNSvariants in vitro, as well as the localization of aV integrins in vivo in transfected rat renal tubular cells. They also increase the number of Na-Kpumpunits exposed on the cell surface and their activity (40) . These observations indicate that adducin plays a crucial role in the regulation of transepithelial sodium transport and contributes to the tubular sodium reabsorption responsible for hypertension in this strain.
Evidence in humanhypertension
The association of adducin polymorphisms with humanhypertension has been investigated in recent years. Linkage analysis in Caucasian populations reveals a significant association between an alpha-adducin polymorphism (Gly 460 Tip) and hypertension. Moreover, treatment with hydrochlorothiazide for two monthscauses a greater fall in the meanarterial blood pressure in hypertensive patients who are heterozygous for the mutant allele (Gly/Trp) than in wild-type homozygous (Gly/ Gly) hypertensive patients. These observations suggest that alpha-adducin is associated with a salt-sensitive form of essential hypertension (41) . In contrast, a very recent report suggests that the alpha-adducin polymorphism (Gly 460 Trp) is unlikely to have a major effect on the susceptibility of the Japanese population to hypertension. However, this study does not exclude the involvement of alpha-adducin in the pathogenesis of hypertension because the 460Trp variant appears to be relatively commonin the Japanese (54 to 60%) compared with a reported prevalence of 13 to 23% in Caucasians (42) .
Epithelial Sodium Channel
Evidence in experimentai models A hypothesis has been proposed that missense mutation or truncations of the epithelial sodium channel found in Liddle's syndromemight also contribute to common polygenic forms of hypertension. A study using SHRSPand WKYshows that in the rat, the beta-and gamma-subunits of the epithelial sodium channel, as in humans, are in close linkage; they map to rat chromosome 1 and cosegregate with systolic blood pressure following dietary intake of NaCl. The alpha-subunit mapping on chromosome4 has no effect on blood pressure. A comparative analysis of the complete coding sequences of all three subunits in the SHRSPand WKYreveals no biologically relevant mutations. Moreover, no differences are found in the mRNA levels of all three subunits in the kidneys of these strains. These observations do not support a crucial contribution of the epithelial sodium channel genes to blood pressure regulation in the polygenic hypertension of SHRSP (43) .
Evidence in humanhypertension
Liddle's syndrome (pseudoaldosteronism) is an autosomal dominant form of humanhypertension characterized by early onset of hypertension, typically associated with hypokalemia, suppressed plasma rennin activity and low aldosterone concentration. Linkage studies in Liddle's original kindred demonstrate a linkage of this trait to a segmentof humanchromosome 16 that contains two candidate genes of interest, betaand gamma-subunits of the epithelial sodium channel. The investigation of these channel genes in Liddle's syndrome kindred reveals the mutations of the beta-subunit in each that results in the deletion of the normal cytoplasmic carboxyl terminus of the encoded protein (44). The expression of the epithelial sodium channels containing mutant beta-and gamma-subunits results in their constitutive activation (45). Another investigation of Liddle's syndrome in the Japanese demonstrated no mutation in the beta-subunit of the epithelial sodium channel, but the presence of a mutation truncating the cytoplasmic C-terminus of the gamma-subunit, suggesting the genetic heterogeneity of Liddle's syndrome (46).
Na-K-ATPase
Na-K-ATPase, biochemically equivalent to a sodium pump, is an integral membraneprotein responsible for establishing the electrochemical gradient of sodium and potassium ions across the plasma membraneof mammaliancells. This enzyme activity or structure is regulated by adducin, the cytoskeletal protein which modulates the membrane structure as described earlier, as well as several hormones including dopamine, vasoactive peptide and cytochrome P450 metabolites. A genetic defect or disorder of adducin, the renal dopamine system or cytochrome P450 results in an elevation of blood pressure associated with enhanced renal tubular Na-K-ATPase activity (Fig.1 ).
Renal Dopamine System
Evidence in experimental models Dopamineplays an important role in the regulation of renal function. In addition to its well-known hemodynamiceffects, dopamineproduces a natriuresis through a direct action on the renal tubule, attributed in part to the inhibition of Na-KATPase in the renal epithelial cells. Dopamine inhibits Na-KATPase in the proximal tubule through complex intracellular signal transduction via its Dl receptor. The Dahl salt-sensitive rat and SHR,which have normal dopamine production and expression of dopamine receptors in the kidney, have a defect in the coupling of D l receptor to the GS-protein/effector enzyme complex. A consequence of the defective D l receptor/effector enzyme coupling is a decreased ability of Dl agonist to inhibit Na-K-ATPaseactivity causing the elevation of blood pressure (47) . The Dl receptors in the kidney are classified into D1A, a major Dl receptor expressed in the renal proximal tubule, and D1B subtypes. The blood pressure in mice lacking functional DlAreceptor is higher in homozygousand heterozygous mice than in normal controls, suggesting a causal relationship of the D 1A receptor gene with hypertension (48) .
Evidence in human hypertension
In contrast to the results in experimental hypertensive model rats, in humanhypertension, it is not yet clarified whether the disorder of the renal dopaminesystem results in the elevation of blood pressure in relation to renal Na-K-ATPase. Hypertensive subjects, however, have less renal dopamine production for the amount of sodium ingested and a decreased renal dopamine production in response to a protein load as compared with normotensive subjects, consistent with a renal defect in conversion of DOPAto dopamine (49) . Similarly, dopaminuric response to a high sodium diet is decreased in individuals with familial hypertension, suggesting the relationship between the renal dopaminergic defect and the development of hypertension (50) . Further investigations will be necessary to prove that the renal dopaminergic defect in humanhypertension involves an alteration in the renal Na-K-ATPase.
Ouabain-Like Factor
Evidence in experimental models The amount of OLFin tissue from Milan hypertensive strain is higher than that from Milan normotensive strain, suggesting the role of OLFin the pathogenesis in MHShypertension (5 1). Increased secretion of OLFmay lead to elevated cytosolic Ca2+ and vasoconstriction, responsible for the development and perpetuation of hypertension. OLFhas been thus thought to play important roles in long-term blood pressure control (52) . A recent observation by Rayson demonstrated that a circulating Na7K+-ATPaseinhibitor maynot be effective in eliciting chronic forms of hypertension unless the homeostatic response of the target cell is impaired, as apparent in the Dahl salt-sensitive rats (53) .
Evidence in human hypertension Accumulating evidence has suggested that several sodium pumpinhibitors, similar to cardiotonic steroids, are present in the human body (54) . Ouabain-like factor, the most appealing candidate, has been found to increase with high sodium intake and hypervolemia, as well as essential hypertension (55) .
Cytochrome P450
Arachidonic acid is metabolized in the kidney by the cytochrome P450-dependent monooxygenase. These metabolites exert renal vasodilation and inhibition of tubular Na-K-ATPase activity, and are thought to be closely related to the pathogenesis of hypertension. The production of 20-HETE by P450 monooxygenasein the outer medulla of the kidney (56), as well as the expression of cytochrome P450 itself (57) is reduced in Dahl salt-sensitive rats (Fig. 1) . Furthermore, the cytochrome P450 genotype cosegregates with hypertension in Dahl salt-sensitive rats. The P450 locus is located on rat chromosome5, where a quantitative trait locus for blood pressure has been detected (56).
Other Genetic Factors which Affect Na-K-ATPase Na-K-ATPaseis an enzymecomposed of alpha and beta subunits, alpha being the catalytic subunit. The alpha subunit of Na-K-ATPase has three isoforms, alpha-1, -2 and -3. The main isoform detected in the renal tubules is alpha-1. An adenine (A) 1079 to thymine (T) transversion, resulting in the substitution of glutamine at position 276 with leucine. This is associated with decreased net 86Rb+ uptake exerted by Na-KATPase in the Dahl salt-sensitive rats, suggesting a putative role of this enzyme in the pathogenesis of hypertension (58) .
Endothelin
The endothelin system, consisting of a series of potent vasoconstrictive peptides and their receptors, is potentially important in the regulation of blood pressure. The gene coding for endothelin-2 (ET-2) (59) and ET-3 (60) that are located on chromosome5 and on chromosome3, respectively, cosegregate strongly with systolic blood pressure in the Dahl salt-sensitive rats. Moreover, the augmentation of gene expression of endothelin converting enzyme-1 (ECE-1), an enzyme that synthesizes bioactive ET-1 in the nephron, may contribute to the development of hypertension through the increase in ET-1 synthesis resulting in the enhancement of sodium retention in the kidney in SHR (61) . The endothelin receptors are classified into ETAand ETBsubtypes. In the renal cortex from SHR, the ratio of ETAto ETBdiminishes compared with that from the normotensive SD rats. The affinity of ET receptors in SHRis also higher than that in SD rats. These observations indicate the distribution and functional roles of ETAand ETBreceptors in the pathogenesis of hypertension in SHR(62).
Atrial Natriuretic Factor or Peptide
Atrial natriuretic factor (ANF) or peptide (ANP) exerts multiple potent antihypertensive actions via its receptor and guanylate cyclase. ANFexhibits vasodilation, suppression of plasma renin activity, inhibition of the synthesis and release of aldosterone, and promotes diuresis and natriuresis. In experimental models, ANPknockout mice develop salt-sensitive hypertension (63, 64) in part due to their inability to reduce plasma renin activity (64) . On the other hand, disruption of the guanylate cyclase-A gene results in salt-resistant hypertension in mice (65) . In humanhypertension, mutations in the ANP gene are observed more prominently among African hypertensive individuals (66) .
Nitric Oxide and Its Synthase
Nitric oxide (NO) produced by nitric oxide synthase (NOS) plays a significant role in the regulation of systemic and renal hemodynamicsand sodium excretion. Alles of the inducible NOS(iNOS) that map on rat chromosome 10 cosegregate with the blood pressure in SHR (67) . A disruption of the endothelial NOS(eNOS) in mice results in hypertension, indicating that eNOSmediates basal vasodilation (68) . In the Sabra salt-sensitive (SBH/y) and Sabra salt-resistant (SBN/y) rats, deoxycoticosterone acetate (DOCA) salt induces a decrease in the activity of the renin-angiotensin system but does not change the gene expression of NOS. Inducible and neural NOSgene expression are less prominent in SBH/y than in SBN/y, independent of DOCA-salt administration, suggesting that the NO system may contribute in part to the salt resistance of SBN/y (69). However, the genotypes of NOSare not related to human essential hypertension (70) . 
